Alternatives to Ipsen
Ipsen is a Biotech tool: global biopharmaceutical company focused on oncology, rare diseases, and neuroscience. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Ipsen
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
Biogen36BiotechCambridge, United StatesGlobal biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.
- Website
Aelis Farma43BiotechnologyBordeaux, France$54.3MClinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
- Website
Bristol Myers Squibb22BiotechNew York, United StatesA global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.
- Website
AbbVie9BiotechnologyNorth Chicago, United StatesA global research-based biopharmaceutical company focused on developing advanced therapies for complex medical conditions.
- Website
Jazz Pharmaceuticals24BiotechnologyDublin, Ireland$265.0MGlobal biopharmaceutical company focused on oncology and neuroscience treatments.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Showing the 20 closest matches. See the rest on the Ipsen profile.
Compare Ipsen head to head
Side by side on what each one does, what it costs, and what real users report.